New US nanotech alliance draws from EU mechanisms

In an interesting turnabout, the US National Cancer Institute (NCI) has just launched a new scheme to jumpstart nanotechnology-based cancer treatments and standards which seems to draw on the EU’s new research instruments under the Sixth Framework Programme (FP6).

Read more here.

Source: European Commission